V., Zamboni, P
FiorelliSPorroBCosentinoNDi MinnoAManegaCMFabbiocchiFet alActivation of Nrf2/HO-1 pathway and human atherosclerotic plaque vulnerability: an in vitro and in vivo study
R.GowanK.LaBergeG
Tuy tinh cht hu b dng nhng b sung qu nhiu cng khng qu tt
But with that said, there are some treatments that are commonly used to help slow the spread of depigmentation
Sections were then incubated overnight at 4 C with primary antibodies, including anti-xCT (1:250, Abcam, ab307601), anti-GPX4 (1:50, Abcam, ab125066), anti-LCN2 (1:250, Abcam, ab216462), anti-MDA (1:200, Abcam, ab243066), anti-SOST (1:100, R&D Systems, BAF1589), anti-DKK1 (1:100, ProteinTech, 21112-1-AP), and anti-active--catenin (1:500, Abcam, ab305261)